Cell Cryopreservation Market Share

  • Report ID: 5636
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Cell Cryopreservation Market Share

APAC Market Forecast

The cell cryopreservation market in the Asia Pacific region is projected to hold the largest revenue share of 38% by the end of 2037. The increasing prevalence of chronic diseases in the Asia Pacific region is a key driver for the growth of the market. As chronic diseases such as cardiovascular diseases, diabetes, and cancer continue to escalate, there is a growing need for advanced cell-based therapies. According to a report by the World Health Organization (WHO), non-communicable diseases accounted for 71% of all deaths in the Asia Pacific region. This statistic emphasizes the urgent demand for innovative medical solutions, including cell cryopreservation, to support the development of cell-based therapies. Asia Pacific has been at the forefront of stem cell research, contributing to the growth of the cell cryopreservation market. Ongoing advancements in understanding stem cell biology and therapeutic applications are driving the need for effective cryopreservation techniques. The Asia Pacific region is witnessing substantial growth in the biotechnology sector, with a focus on cell-based therapies, genomics, and personalized medicine. The expanding biotechnology industry is a significant driver for the cell cryopreservation market as it necessitates advanced cell preservation methods.

North American Market Statistics

The cell cryopreservation market in the North American region is projected to hold the second-largest share during the forecast period. The elevated prevalence of chronic diseases in North America acts as a significant driver for the cell cryopreservation market. Chronic conditions such as cardiovascular diseases, diabetes, and cancer drive the demand for innovative cell-based therapies, emphasizing the importance of effective cryopreservation techniques. This staggering statistic underscores the urgent need for advanced medical solutions, including cell cryopreservation, to address the increasing burden of chronic illnesses. North America, particularly the United States, plays a pioneering role in biotechnology and scientific research. The region's leadership in innovative research initiatives and cutting-edge technologies fuels the demand for cell cryopreservation, which is integral to preserving the viability of cells used in diverse research applications.

Research Nester
Cell Cryopreservation Market size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5636
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell cryopreservation is estimated at USD 12.9 billion.

Cell Cryopreservation Market size was valued at USD 11.06 billion in 2024 and is poised to cross USD 129.01 billion by the end of 2037, expanding at more than 20.8% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for the healthcare sector will drive the market growth.

Asia Pacific industry is set to account for largest revenue share of 38% by 2037, impelled by surge in research and development efforts in the region.

The major players in the market are Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, BioLife Solutions, Inc., Charter Medical, Ltd., STEMCELL Technologies Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample